LXEO
Price
$8.56
Change
+$0.06 (+0.71%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
459.01M
60 days until earnings call
Intraday Buy/Sell Signals
TSHA
Price
$5.33
Change
+$0.17 (+3.29%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
1.41B
27 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

LXEO vs TSHA

Header iconLXEO vs TSHA Comparison
Open Charts LXEO vs TSHABanner chart's image
Lexeo Therapeutics
Price$8.56
Change+$0.06 (+0.71%)
Volume$100
Capitalization459.01M
Taysha Gene Therapies
Price$5.33
Change+$0.17 (+3.29%)
Volume$7.45K
Capitalization1.41B
LXEO vs TSHA Comparison Chart in %
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LXEO vs. TSHA commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LXEO is a Hold and TSHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (LXEO: $8.50 vs. TSHA: $5.16)
Brand notoriety: LXEO and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LXEO: 100% vs. TSHA: 68%
Market capitalization -- LXEO: $459.01M vs. TSHA: $1.41B
LXEO [@Biotechnology] is valued at $459.01M. TSHA’s [@Biotechnology] market capitalization is $1.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LXEO’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • LXEO’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, both LXEO and TSHA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LXEO’s TA Score shows that 3 TA indicator(s) are bullish while TSHA’s TA Score has 5 bullish TA indicator(s).

  • LXEO’s TA Score: 3 bullish, 4 bearish.
  • TSHA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TSHA is a better buy in the short-term than LXEO.

Price Growth

LXEO (@Biotechnology) experienced а +1.92% price change this week, while TSHA (@Biotechnology) price change was +9.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.44%. For the same industry, the average monthly price growth was +17.42%, and the average quarterly price growth was +81.94%.

Reported Earning Dates

LXEO is expected to report earnings on Dec 15, 2025.

TSHA is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($1.41B) has a higher market cap than LXEO($459M). TSHA YTD gains are higher at: 197.977 vs. LXEO (29.179). TSHA has higher annual earnings (EBITDA): -91.48M vs. LXEO (-111.97M). TSHA has more cash in the bank: 313M vs. LXEO (133M). LXEO has less debt than TSHA: LXEO (8.91M) vs TSHA (59.6M). TSHA has higher revenues than LXEO: TSHA (8.1M) vs LXEO (0).
LXEOTSHALXEO / TSHA
Capitalization459M1.41B33%
EBITDA-111.97M-91.48M122%
Gain YTD29.179197.97715%
P/E RatioN/A2.70-
Revenue08.1M-
Total Cash133M313M42%
Total Debt8.91M59.6M15%
TECHNICAL ANALYSIS
Technical Analysis
LXEOTSHA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PNDZF138.50N/A
N/A
Pandora A/S
WLTNF0.30N/A
N/A
Wilton Res Inc
AOZOY3.92N/A
N/A
Aozora Bank Ltd.
ZMTBY2.27N/A
N/A
Zumtobel AG
TCEHY80.25-1.38
-1.69%
Tencent Holding Ltd.

LXEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with ARWR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
+3.66%
ARWR - LXEO
43%
Loosely correlated
-0.80%
COGT - LXEO
43%
Loosely correlated
-4.72%
VTYX - LXEO
43%
Loosely correlated
-1.48%
IPSC - LXEO
42%
Loosely correlated
+1.84%
RGNX - LXEO
42%
Loosely correlated
-0.71%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with PCVX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
+2.08%
PCVX - TSHA
43%
Loosely correlated
-2.19%
RGNX - TSHA
39%
Loosely correlated
-0.71%
DYN - TSHA
35%
Loosely correlated
+10.26%
XNCR - TSHA
35%
Loosely correlated
-11.03%
ORMP - TSHA
35%
Loosely correlated
-2.07%
More